Provided by Tiger Trade Technology Pte. Ltd.

IT Tech Packaging Inc

0.1560
-0.0078-4.76%
Volume:143.56K
Turnover:22.98K
Market Cap:2.65M
PE:-0.18
High:0.1648
Open:0.1629
Low:0.1560
Close:0.1638
52wk High:0.3900
52wk Low:0.1506
Shares:16.97M
Float Shares:16.42M
Volume Ratio:1.11
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8619
EPS(LYR):-0.9779
ROE:-6.92%
ROA:-3.36%
PB:0.02
PE(LYR):-0.16

Loading ...

It Tech Packaging Auditor Resigns Amid Dispute over Us$1.05 Million CEO Loan Accounting

Reuters
·
Sep 02

It Tech Packaging - Disagreement over Accounting Treatment of Us$1,050,000 Loan to CEO - SEC Filing

THOMSON REUTERS
·
Sep 02

It Tech Packaging - Montis Cpa Resigns as it Tech Packaging's Independent Auditor Effective August 27, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 02

IT Tech Packaging trading halted, news pending

TIPRANKS
·
Sep 02

Amex Halt News Pending Lst 0.176300

THOMSON REUTERS
·
Sep 02

Press Release: InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones Achieved

Dow Jones
·
Aug 24

Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire
·
Aug 24

It Tech Packaging Tunda Rilis Laporan Keuangan Kuartal II 2026, Ajukan Pemberitahuan Keterlambatan 10-Q

Reuters
·
Aug 12

Press Release: Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 06

Agios Reports Second Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Jul 30

Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins

GlobeNewswire
·
Jul 16

Press Release: Bionano Announces Hiring of Chief Scientific Officer

Dow Jones
·
Jun 24

Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders

GlobeNewswire
·
Jun 11

Climb Bio Reports Encouraging Early Budoprutug ITP Data

TIPRANKS
·
Jun 11

Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026

GlobeNewswire
·
Jun 11

Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases

GlobeNewswire
·
Jun 10

argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026

GlobeNewswire
·
Jun 03

Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib

GlobeNewswire
·
Jun 01

InnoCare Pharma Gets Acceptance for ITP New Drug Application; Shares Up 3%

MT Newswires Live
·
May 29

Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures

GlobeNewswire
·
May 28